A Multicenter, Phase Ib/II Clinical Trial to Evaluate the Efficacy and Safety of Concurrent Combination Therapy of S-531011 Plus Fruquintinib or S-531011 Plus Fruquintinib Plus Pembrolizumab in Patients With MSS/pMMR Colorectal Cancer

Clinical trial NCT07591597 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07591597
Sponsor: National Cancer Center Hospital East
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Neoplasms Microsatellite Stable / Proficient Mismatch Repair Colorectal Cancer

Start date: 2026-05-01
Primary completion: 2027-07-01
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.